Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPPL1 | O15357 | 11/20 | 0.50 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.50 |
| ▸ | INPP5B | P32019 | 2/20 | 0.50 |
| ▸ | SRC | P12931 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2175835 | 0.98 | INPPL1 (0.52) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL2196909 | 0.85 | MYC (0.38) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL9315209 | 0.81 | INPPL1 (0.50) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL28712123 | 0.81 | ELANE (0.56) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL1593349 | 0.80 | GPR84 (0.37) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL28618568 | 0.77 | SRC (0.44) | SRCKDM4EALDH1A1 | |
| SCHEMBL2573126 | 0.77 | INPPL1 (0.70) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL28494979 | 0.77 | INPPL1 (0.39) | INPPL1INPP5AINPP5BSRCKDM4E | |
| SCHEMBL5698446 | 0.76 | MYC (0.42) | ALDH1A1HSD17B10MYCELANE | |
| SCHEMBL8983185 | 0.76 | MYC (0.42) | ALDH1A1HSD17B10MYCELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9023553-B2 | Multilayered composite proton exchange membrane and a process for manufacturing the same | CHEMSULTANTS INTERNATIONAL, INC. (US) | 2015-05-05 | — | — | US | claimed |
| US-20150299877-A1 | MATERIAL FOR AN ELECTROCHEMICAL DEVICE | CERAM HYD (FR) | 2015-10-22 | — | — | US | disclosed |
| US-9105907-B2 | Material for an electrochemical device | CERAM HYD (FR) | 2015-08-11 | — | — | US | disclosed |
| US-9023553-B2 | Multilayered composite proton exchange membrane and a process for manufacturing the same | CHEMSULTANTS INTERNATIONAL, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-20140107135-A1 | PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2014-04-17 | — | — | US | disclosed |
| US-8507147-B2 | Proton exchange membrane and cell comprising such a membrane | CERAM HYD (FR) | 2013-08-13 | — | — | US | disclosed |
| US-8383692-B2 | Method of activating boron nitride | CERAM HYD (FR) | 2013-02-26 | — | — | US | disclosed |
| US-7977008-B2 | High temperature proton exchange membrane using ionomer/solid proton conductor, preparation method thereof and fuel cell containing the same | Industry-University Cooperation Foundation Sogang University (KR) | 2011-07-12 | — | — | US | disclosed |
| US-7973109-B2 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20110091789-A1 | MATERIAL FOR AN ELECTROCHEMICAL DEVICE | CERAM HYD (FR) | 2011-04-21 | — | — | US | disclosed |
| US-20100279201-A1 | PROTON EXCHANGE MEMBRANE AND CELL COMPRISING SUCH A MEMBRANE | CERAM HYD (FR) | 2010-11-04 | — | — | US | disclosed |
| US-20100280138-A1 | METHOD OF ACTIVATING BORON NITRIDE | GEN-HY (FR) | 2010-11-04 | — | — | US | disclosed |
| US-20090176141-A1 | Multilayered composite proton exchange membrane and a process for manufacturing the same | CHEMSULTANTS INTERNATIONAL, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| WO-2009073055-A1 | MULTILAYERED COMPOSITE PROTON EXCHANGE MEMBRANE AND A PROCESS FOR MANUFACTURING THE SAME | CHEMSULTANTS INTERNATIONAL, INC. (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-04-09 | — | — | US | disclosed |
| US-20070026284-A1 | High temperature proton exchange membrane using ionomer/soild proton conductor, preparation method thereof and fuel cell containing the same | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2007-02-01 | — | — | US | disclosed |
| WO-2005006474-A1 | HIGH TEMPERATURE PROTON EXCHANGE MEMBRANE USING IONOMER/SOILD PROTON CONDUCTOR, PREPARATION METHOD THEREOF AND FUEL CELL CONTAINING THE SAME | SOGANG UNIVERSITY (KR) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | WEE1, WEE2, PPIP5K2 | INPPL1 64/4885INPP5A 68/4885INPP5B 26/4885 |
| US-20140107135-A1 | PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 | PLA2G1B, PLA2G4A, PLA2G4B | INPPL1 240/4885INPP5A 223/4885INPP5B 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.